Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)

Trial ID or NCT#

NCT04551950

Status

not recruiting iconNOT RECRUITING

Purpose

This study was to evaluate the safety and tolerability of bintrafusp alfa in combination with other anti-cancer therapies in participants with locally advanced or advanced cervical cancer.

Official Title

Safety Study of Bintrafusp Alfa in Combination With Other Anti-cancer Therapies in Participants With Locally Advanced or Advanced Cervical Cancer (INTR@PID 046)

Eligibility Criteria

Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Oliver Dorigo
Oliver Dorigo
Gynecologic oncologist, Medical oncologist, Gynecologic oncologist
Mary Lake Polan Professor

Contact us to find out if this trial is right for you.

Contact

Akschy Peer
650-736-0792

View on ClinicalTrials.gov